Summary
This business specializes in advanced AI-powered technology designed to assist clinicians in planning and performing neurovascular surgeries. Their flagship product, PreSize® Neurovascular, allows users to create patient-specific blood vessel models from routine scans, enabling the selection of the best-fit implant devices before surgery. The technology aims to enhance surgical accuracy, reduce complications, and improve patient outcomes, while also engaging in clinical trials and research to validate its effectiveness.
Based on content on oxfordheartbeat.com
No similar companies found
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
9.2 years — Since Nov 2015
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
541714
SIC 4 Digit Code
3845
SIC 2 Digit Code
38
Industry
1. Medical Technology
2. Research and Development in Biotechnology (except Nanobiotechnology)
No vendors identified.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|